PLAUR and COVID-19: Recently, soluble urokinase plasminogen activator receptor (suPAR), which plays a role in various inflammation-related diseases and infections, including acute pancreatitis, systemic inflammatory syndrome, renal failure, bacteremia, and sepsis, has gained significant attention due to its potential value in predicting severe respiratory failure (SRF) associated with COVID-19 [4,5,6].